Canada’s Evolving Life Sciences Industry:
Exploring Ecosystems, Clusters, and the Need for Anchor Companies

The first white paper considers the role of innovation ecosystems, advantages of industrial clusters, and impact of anchor companies on the life sciences industry.


This paper describes how innovation ecosystems differ from clusters, and explores the symbiosis that exists among the component parts. We also propose a definition of research-based anchor companies in the Canadian context and explore the critical roles they play in leading internationally prominent life science clusters – a role that is absent in Canada.

Read the report

After the challenges of the past three years, Canadian life sciences is experiencing a generational moment. The actors of this sector must respond to this momentum, and one way to respond is to collaborate in establishing a fact-based, research-proven roadmap.

Canada has an extraordinary opportunity to truly become a global life sciences leader. To seize this opportunity, we need to be clear about the data and the facts at its foundation and have a candid dialogue about public policy issues.

Gordon C. McCauley

President & CEO,
adMare BioInnovations

Advisory committee

An advisory committee will be formed to give their insights and expertise on the Institute's work.

The composition will be announced shortly.

Paul Buron

John DeLucchi

Theresa Firestone

Patricia Gauthier

Nancy Harrison

Martin LeBlanc

Gordon C. McCauley

Travis McCready

Laurence Rulleau

Michelle Savoie

Tim van Biesen